The Technical Analyst
Select Language :
Vincerx Pharma, Inc. [VINC]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Vincerx Pharma, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Vincerx Pharma, Inc. is listed at the  Exchange

-16.50% $5.06

America/New_York / 28 mar 2024 @ 16:00


Vincerx Pharma, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 108.19 mill
EPS: -2.31
P/E: -2.19
Earnings Date: Mar 27, 2024
SharesOutstanding: 21.38 mill
Avg Daily Volume: 1.089 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.19 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.37x
Company: PE -2.19 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.391
(-92.27%) $-4.67
Date: 2024-03-28
Expected Trading Range (DAY)

$ 4.33 - 5.79

( +/- 14.41%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-07 Izumi Raquel E. Buy 123 750 Stock Option (right to buy)
2024-03-07 Seelenberger Alexander A. Buy 93 750 Stock Option (right to buy)
2024-03-07 Hamdy Ahmed Md Buy 146 746 Stock Option (right to buy)
2024-03-07 Thomas Tom C Buy 93 750 Stock Option (right to buy)
2023-08-11 Seelenberger Alexander A. Buy 10 500 Common Stock
INSIDER POWER
100.00
Last 97 transactions
Buy: 7 261 732 | Sell: 1 766 942

Forecast: 16:00 - $5.01

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $5.01
Forecast 2: 16:00 - $5.01
Forecast 3: 16:00 - $5.01
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $5.06 (-16.50% )
Volume 0.602 mill
Avg. Vol. 1.089 mill
% of Avg. Vol 55.27 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Vincerx Pharma, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Vincerx Pharma, Inc.

RSI

Intraday RSI14 chart for Vincerx Pharma, Inc.

Last 10 Buy & Sell Signals For VINC

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Vincerx Pharma, Inc.

VINC

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

Last 10 Buy Signals

Date Signal @
VRXUSDMar 29 - 02:1960.44
^N300Mar 29 - 02:00594.52
CBKUSDMar 29 - 02:151.087
ORCAUSDMar 29 - 02:153.83
TRXUSDMar 29 - 02:10$0.120
BADGERUSDMar 29 - 02:117.11
INDEXUSDMar 29 - 02:085.97
FUMOUSDMar 29 - 02:109 998.30
FTNUSDMar 29 - 02:101.819
OMGUSDMar 29 - 02:08$1.092

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.